Land: Irland
Sprog: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
Cloprostenol
Vetoquinol UK Limited
QG02AD90
Cloprostenol
0.250 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle
cloprostenol
Hormone
Authorised
2017-04-28
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Bioestrovet 0.250 mg/ml solution for injection for cattle 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Solution for injection. A clear colourless aqueous solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (heifers, cows). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cattle (heifers, cows): - Induction of luteolysis allowing resumption of oestrus and ovulation in cyclic females when used during dioestrus - Synchronisation of oestrus (within 2 to 5 days) in groups of cyclic females treated simultaneously - Treatment of suboestrus and uterine disorders related to a functioning or persistent corpus luteum (endometritis, pyometra) - Treatment of ovarian luteal cysts - Induction of abortion until day 150 of pregnancy - Expulsion of mummified foetuses - Induction of parturition 4.3 CONTRAINDICATIONS Do not administer to pregnant animals unless the objective is to terminate the pregnancy. Do not use in animals with cardiovascular, gastro-intestinal or respiratory problems. Do not administer to induce parturition in cattle with suspected dystocia due to mechanical obstruction or if problems are expected because of an abnormal position of the foetus. Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not administer intravenously. Each ml contains: ACTIVE SUBSTANCE: Cloprostenol 0.250 mg (equivalent to Cloprostenol Sodium) 0.263 mg EXCIPIENTS: Chlorocresol 1.00 mg For the full list of excipients, see section 6.1. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ Læs hele dokumentet